Similar articles for PMID: 6439036

Year	Number of Results
1982	5
1983	6
1984	13
1985	12
1986	12
1987	18
1988	20
1989	18
1990	20
1991	13
1992	24
1993	10
1994	13
1995	15
1996	15
1997	8
1998	10
1999	10
2000	10
2001	10
2002	10
2003	9
2004	13
2005	14
2006	5
2007	12
2008	5
2009	10
2010	7
2011	4
2012	5
2013	5
2014	5
2015	8
2016	9
2017	11
2018	5
2019	10
2020	7
2021	19
2022	12
2023	5
2024	0

1

Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

Osei K, O'Dorisio TM, Falko JM. Osei K, et al. Am J Med. 1984 Dec;77(6):1002-9. doi: 10.1016/0002-9343(84)90179-7. Am J Med. 1984. PMID: 6439036 Clinical Trial.

2

Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.

Falko JM, Osei K. Falko JM, et al. Am J Med. 1985 Sep 20;79(3B):92-101. doi: 10.1016/s0002-9343(85)80014-0. Am J Med. 1985. PMID: 3931467 Clinical Trial.

3

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

DeFronzo RA, Goodman AM. DeFronzo RA, et al. N Engl J Med. 1995 Aug 31;333(9):541-9. doi: 10.1056/NEJM199508313330902. N Engl J Med. 1995. PMID: 7623902 Free article. Clinical Trial.

4

Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent.

Osei K, Falko JM. Osei K, et al. Am J Med Sci. 1985 Apr;289(4):148-53. doi: 10.1097/00000441-198504000-00004. Am J Med Sci. 1985. PMID: 3920907

5

Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.

Dailey GE 3rd, Mohideen P, Fiedorek FT. Dailey GE 3rd, et al. Clin Ther. 2002 Sep;24(9):1426-38. doi: 10.1016/s0149-2918(02)80046-7. Clin Ther. 2002. PMID: 12380634

6

Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.

Riddle M, Hart J, Bingham P, Garrison C, McDaniel P. Riddle M, et al. Am J Med Sci. 1992 Mar;303(3):151-6. doi: 10.1097/00000441-199203000-00003. Am J Med Sci. 1992. PMID: 1595776 Clinical Trial.

7

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R. Roberts VL, et al. Clin Ther. 2005 Oct;27(10):1535-47. doi: 10.1016/j.clinthera.2005.10.017. Clin Ther. 2005. PMID: 16330290 Clinical Trial.

8

Treatment of type I diabetes with a combination of glyburide and insulin.

Gums JG, Curry RW Jr, Montes de Oca G, Skluth HA, Reynolds LR. Gums JG, et al. Ann Pharmacother. 1992 Jun;26(6):757-62. doi: 10.1177/106002809202600601. Ann Pharmacother. 1992. PMID: 1611155 Clinical Trial.

9

Effects of combined insulin-sulfonylurea therapy in type II patients.

Lewitt MS, Yu VK, Rennie GC, Carter JN, Marel GM, Yue DK, Hooper MJ. Lewitt MS, et al. Diabetes Care. 1989 Jun;12(6):379-83. doi: 10.2337/diacare.12.6.379. Diabetes Care. 1989. PMID: 2499443 Clinical Trial.

10

Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial.

Schade DS, Mitchell WJ, Griego G. Schade DS, et al. JAMA. 1987 May 8;257(18):2441-5. JAMA. 1987. PMID: 3106656 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

431 results

Results by year